<DOC>
	<DOCNO>NCT02251379</DOCNO>
	<brief_summary>This study evaluate effect add environmental home intervention standard asthma medication management controller medication requirement among child adolescent asthma . The investigator hypothesize addition individually-tailored , multi-faceted Environmental Control Strategy ( ECS ) guidelines-based controller medication result less controller medication requirement allergic inflammation controller medication alone among urban asthmatic child .</brief_summary>
	<brief_title>Environmental Control Add-on Therapy Childhood Asthma</brief_title>
	<detailed_description>The study parallel arm study individually tailor , multi-faceted ECS plus controller medication titration versus controller medication titration alone . After 4-week run-in period stabilize asthma , investigator randomize 200 Baltimore child persistent asthma recent exacerbation 1:1 ratio two arm follow six month . There five clinic visit three home visit time period clinical home assessment , respectively . There four environmental intervention visit participant randomized environmental control plus controller medication group . The environmental module include mouse , cockroach , furry pet , dustmites , smoking . Air purifier launder bedding also include arm . Participants randomize controller medication group option one home visit complete study participant receive home intervention service environmental control plus controller medication group receive . Participants repeat assessment : controller medication requirement ; secondary clinical , physiologic , inflammatory outcome ; particulate matter ( PM ) , air nicotine , allergen level .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Have physiciandiagnosed asthma least 1 year prior baseline visit , asthma symptom least 1 year Meet criterion current persistent asthma define either : 1 . On longterm controller medication asthma , 2 . Meet NAEPP guideline requirement persistent disease : ( 46 ) Asthma symptom 3 day per week past 2 week OR Nocturnal asthma symptom least 3 time past month Have evidence uncontrolled disease define least one following : 1 . One asthmarelated unscheduled visit emergency department ( ED ) , clinic urgent care facility previous 12 mo 2 . One asthmarelated overnight hospitalization previous 12 mo 3 . One burst oral corticosteroid previous 12 mo Reside within geographic area study site home visit feasible . Have plan move within upcoming 6 month Have insurance cover prescription medication . Have positive skin test ( net wheal ≥2mm ) cat , dog , mouse , cockroach , dust mite positive cat , dog , mouse , German cockroach , D. farinaespecific IgE test , quantify use ImmunoCAP system ( ≥0.35 kU/L ) Lung disease , asthma , require daily medication Cardiovascular disease require daily medication , exclude hypertension Taking betablocker Allergy dairy On Xolair &lt; 5 month On immunotherapy reach maintenance dose Sleeping another home 4 nights/week Active smoker define positive urine screen high level urine cotinine Unable access area home necessary conduct extermination</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>